177 related articles for article (PubMed ID: 21627044)
1. Epigenetic dysregulation of epstein-barr virus latency and development of autoimmune disease.
Niller HH; Wolf H; Ay E; Minarovits J
Adv Exp Med Biol; 2011; 711():82-102. PubMed ID: 21627044
[TBL] [Abstract][Full Text] [Related]
2. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of latent Epstein-Barr virus promoters.
Takacs M; Banati F; Koroknai A; Segesdi J; Salamon D; Wolf H; Niller HH; Minarovits J
Biochim Biophys Acta; 2010; 1799(3-4):228-35. PubMed ID: 19853674
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.
Niller HH; Wolf H; Minarovits J
Semin Cancer Biol; 2009 Jun; 19(3):158-64. PubMed ID: 19429479
[TBL] [Abstract][Full Text] [Related]
5. Epigenotypes of latent herpesvirus genomes.
Minarovits J
Curr Top Microbiol Immunol; 2006; 310():61-80. PubMed ID: 16909907
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide DNA methylation as an epigenetic consequence of Epstein-Barr virus infection of immortalized keratinocytes.
Birdwell CE; Queen KJ; Kilgore PC; Rollyson P; Trutschl M; Cvek U; Scott RS
J Virol; 2014 Oct; 88(19):11442-58. PubMed ID: 25056883
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics of Epstein Barr virus - A review.
Shareena G; Kumar D
Biochim Biophys Acta Mol Basis Dis; 2023 Dec; 1869(8):166838. PubMed ID: 37544529
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic control of the Epstein-Barr lifecycle.
Guo R; Gewurz BE
Curr Opin Virol; 2022 Feb; 52():78-88. PubMed ID: 34891084
[TBL] [Abstract][Full Text] [Related]
9. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
10. Methylation of Epstein-Barr virus Rta promoter in EBV primary infection, reactivation and lymphoproliferation.
Germi R; Guigue N; Lupo J; Semenova T; Grossi L; Vermeulen O; Epaulard O; de Fraipont F; Morand P
J Med Virol; 2016 Oct; 88(10):1814-20. PubMed ID: 26990870
[TBL] [Abstract][Full Text] [Related]
11. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.
Dheekollu J; Wiedmer A; Sentana-Lledo D; Cassel J; Messick T; Lieberman PM
J Virol; 2016 Jun; 90(11):5353-5367. PubMed ID: 27009953
[TBL] [Abstract][Full Text] [Related]
12. High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.
Bakos A; Banati F; Koroknai A; Takacs M; Salamon D; Minarovits-Kormuta S; Schwarzmann F; Wolf H; Niller HH; Minarovits J
Virus Genes; 2007 Oct; 35(2):195-202. PubMed ID: 17510783
[TBL] [Abstract][Full Text] [Related]
13. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
Bentz GL; Moss CR; Whitehurst CB; Moody CA; Pagano JS
J Virol; 2015 Aug; 89(15):7465-77. PubMed ID: 25948750
[TBL] [Abstract][Full Text] [Related]
14. PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type.
Lupey-Green LN; Caruso LB; Madzo J; Martin KA; Tan Y; Hulse M; Tempera I
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976663
[TBL] [Abstract][Full Text] [Related]
15. A common mechanism links Epstein-Barr virus infections and autoimmune diseases.
Zhang L
J Med Virol; 2023 Jan; 95(1):e28363. PubMed ID: 36451313
[TBL] [Abstract][Full Text] [Related]
16. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus in autoimmune diseases.
Toussirot E; Roudier J
Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):883-96. PubMed ID: 19028369
[TBL] [Abstract][Full Text] [Related]
18. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
Kalla M; Hammerschmidt W
Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
Gradoville L; Kwa D; El-Guindy A; Miller G
J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
[TBL] [Abstract][Full Text] [Related]
20. EBV and systemic lupus erythematosus: a new perspective.
Gross AJ; Hochberg D; Rand WM; Thorley-Lawson DA
J Immunol; 2005 Jun; 174(11):6599-607. PubMed ID: 15905498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
